Meda: Positive Study Results Presented For Dymista

Links shared publicly online about this topic.

  • 418
    total visits

Meda: Positive Study Results Presented For Dymista

medicalnewstoday.com

Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patie

View full resource at medicalnewstoday.com

Tags: Asthma Medication, COPD Medication, Clinical Trial, Flovent, Flixotide, Flonase, Flixonase

  • Share

Most Recently Shared on March 23, 2011 at 4:47 pm By:

Ear_Nose_Throat Ear, Nose, and Throat

Meda: Positive Study Results Presented For Dymista: Meda (STO:MEDAA) announced positive results from a Phase III... http://bit.ly/dLca5L

1 year ago...

Meda announces positive results from three MP29-02 studies on allergic rhinitis

news-medical.net — “Meda announced today positive results of three studies of MP29-02 (tentatively called Dymista), a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 5, 2012 at 9:00 am By:

wheezemd Michael Blaiss, MD Doctor, Allergist, and Physician

Meda announces positive results from three MP29-02 studies on allergic rhinitis http://t.co/P1LrPqi8

3 months ago...

Meda: Positive Study Results Presented For Dymista

medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patieView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 23, 2011 at 12:05 pm By:

mnt_entnews MNT Ear, Nose Throat Health News

Meda: Positive Study Results Presented For Dymista http://mnt.to/3SCB #entnews

1 year ago...

Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - MPR

empr.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitisView full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 22, 2011 at 6:08 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 Study of Dymista for Seasonal Allergic Rhinitis: Meda announced positive results from its Phas... http://bit.ly/hpduGL

1 year ago...

Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - ONA

oncologynurseadvisor.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitisView full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 22, 2011 at 6:07 pm By:

Meda: Positive Study Results Presented for Dymista - Drugs.com MedNews

drugs.com — “Mar 22, 2011 - Regulatory News Meda (STO MEDAA) announced today positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel forView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 22, 2011 at 2:05 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Meda: Positive Study Results Presented for Dymista: GÖTEBORG, Sweden--(BUSINESS WIRE)--Mar 22, 2011 - Reg... http://bit.ly/f7EXy1 #drug

1 year ago...

Advertisement